21 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
of the Board of Directors qualifies as a “financial expert” as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated
S-3
EX-5.1
CGTX
Cognition Therapeutics Inc
23 Dec 22
Shelf registration
4:16pm
. In rendering this opinion and giving this consent, we do not admit that we are an “expert” within the meaning of the Securities Act.
Very truly yours,
Troutman Pepper Hamilton Sanders LLP
-5-
DEF 14A
14m4yj2pkb 0boajg
25 Apr 22
Definitive proxy
5:28pm
S-8
EX-5.1
07s7jx rl
30 Mar 22
Registration of securities for employees
8:37am
8-K
gsjgtbmbh 9pb
3 Nov 21
Departure of Directors or Certain Officers
4:25pm
S-8
EX-5.1
rlzv0ldvr uqih9v018l
2 Nov 21
Registration of securities for employees
4:51pm
8-K
EX-3.2
zjgmeln bt647xj
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
424B4
nkyckyjp
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1/A
EX-3.8
3u1n5qbb xmd
29 Jul 21
IPO registration (amended)
4:45pm
S-1/A
EX-10.1
udgff b80ff78867c5t
29 Jul 21
IPO registration (amended)
4:45pm
CORRESP
ti1n mtf6
29 Jul 21
Correspondence with SEC
12:00am
S-1
825jcmyc2n l37w2q8dd
19 Jul 21
IPO registration
7:02am
DRS/A
0x3nfrzrah9r01bsob
23 Jun 21
Draft registration statement (amended)
12:00am